Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein.

Krauer KG, Buck M, Belzer DK, Flanagan J, Chojnowski GM, Sculley TB.

Virology. 2004 Jan 5;318(1):280-94.

2.

Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.

Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.

Arch Virol. 2004 Feb;149(2):289-302. Epub 2003 Nov 4.

PMID:
14745596
3.

The EBNA-3 gene family proteins disrupt the G2/M checkpoint.

Krauer KG, Burgess A, Buck M, Flanagan J, Sculley TB, Gabrielli B.

Oncogene. 2004 Feb 19;23(7):1342-53.

PMID:
14716295
5.

Epstein-Barr virus-encoded RK-BARF0 protein expression.

Kienzle N, Buck M, Greco S, Krauer K, Sculley TB.

J Virol. 1999 Oct;73(10):8902-6.

7.

A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle.

Buck M, Cross S, Krauer K, Kienzle N, Sculley TB.

J Gen Virol. 1999 Feb;80 ( Pt 2):441-5.

PMID:
10073706
8.

Intron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genes.

Kienzle N, Young DB, Liaskou D, Buck M, Greco S, Sculley TB.

J Virol. 1999 Feb;73(2):1195-204.

9.

Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.

Kienzle N, Sculley TB, Poulsen L, Buck M, Cross S, Raab-Traub N, Khanna R.

J Virol. 1998 Aug;72(8):6614-20.

10.

Evidence that the expression and phosphorylation status of pleckstrin is modulated by Epstein-Barr virus in human B lymphocytes.

Kienzle N, Cross S, Young DB, Misko I, Sculley TB, Abrams CS.

Blood. 1997 May 1;89(9):3488-90. No abstract available.

PMID:
9129059
11.

Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.

Fries KL, Sculley TB, Webster-Cyriaque J, Rajadurai P, Sadler RH, Raab-Traub N.

J Virol. 1997 Apr;71(4):2765-71.

12.

Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes.

Krauer KG, Kienzle N, Young DB, Sculley TB.

Virology. 1996 Dec 15;226(2):346-53.

13.

Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.

Kerr BM, Kienzle N, Burrows JM, Cross S, Silins SL, Buck M, Benson EM, Coupar B, Moss DJ, Sculley TB.

J Virol. 1996 Dec;70(12):8858-64.

14.

Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family.

Kienzle N, Young D, Silins SL, Sculley TB.

Virology. 1996 Oct 1;224(1):167-74.

15.
16.

DNaseI treatment is a prerequisite for the amplification of cDNA from episomal-based genes.

Kienzle N, Young D, Zehntner S, Bushell G, Sculley TB.

Biotechniques. 1996 Apr;20(4):612-6. No abstract available.

17.
18.

Managing HIV. Part 3: Mechanisms of disease. 3.6 How HIV promotes malignancies.

Boyle MJ, Goldstein DA, Frazer IH, Sculley TB.

Med J Aust. 1996 Feb 19;164(4):230-2. Review. No abstract available.

PMID:
8604195
19.
20.

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

Argaet VP, Schmidt CW, Burrows SR, Silins SL, Kurilla MG, Doolan DL, Suhrbier A, Moss DJ, Kieff E, Sculley TB, Misko IS.

J Exp Med. 1994 Dec 1;180(6):2335-40.

21.

Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes.

Apolloni A, Sculley TB.

Virology. 1994 Aug 1;202(2):978-81.

PMID:
8030259
23.

Epstein-Barr virus-specific cytotoxic T cell response in cardiac transplant recipients.

Kyaw-Tanner MT, Esmore D, Burrows SR, Benson EM, Sculley TB.

Transplantation. 1994 Jun 15;57(11):1611-7.

PMID:
8009596
24.

Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.

Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB.

J Gen Virol. 1994 Jan;75 ( Pt 1):95-100.

PMID:
8113744
25.

EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.

Khanna R, Burrows SR, Suhrbier A, Jacob CA, Griffin H, Misko IS, Sculley TB, Rowe M, Rickinson AB, Moss DJ.

J Immunol. 1993 Jun 1;150(11):5154-62.

PMID:
7684421
26.

The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma.

Boyle MJ, Sculley TB, Penny R, Sewell WA, Tschuchnigg M, Berger MF, Cooper DA.

Leuk Lymphoma. 1993 May;10(1-2):17-23. Review.

PMID:
8397031
27.

Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients.

Kyaw MT, Hurren L, Evans L, Moss DJ, Cooper DA, Benson E, Esmore D, Sculley TB.

AIDS Res Hum Retroviruses. 1992 Nov;8(11):1869-74.

PMID:
1336962
28.

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.

Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.

J Exp Med. 1992 Jul 1;176(1):169-76.

29.

Isolation of Epstein-Barr virus genomes using pulse-field gel electrophoresis.

Silins SL, Argaet VP, Sculley TB.

Nucleic Acids Res. 1992 Jun 11;20(11):2901. No abstract available.

30.

Immune surveillance against Epstein-Barr virus.

Moss DJ, Burrows SR, Khanna R, Misko IS, Sculley TB.

Semin Immunol. 1992 Apr;4(2):97-104. Review.

PMID:
1377517
31.

Epstein-Barr virus and HIV play no direct role in persistent generalized lymphadenopathy syndrome.

Boyle MJ, Sculley TB, Cooper DA, Turner JJ, Penny R, Sewell WA.

Clin Exp Immunol. 1992 Mar;87(3):357-61.

32.

Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.

Misko IS, Schmidt C, Honeyman M, Soszynski TD, Sculley TB, Burrows SR, Moss DJ, Burman K.

Clin Exp Immunol. 1992 Jan;87(1):65-70.

33.

Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma.

Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA.

Blood. 1991 Dec 1;78(11):3004-11.

PMID:
1659471
34.
35.
36.

Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitro.

Schmidt C, Burrows SR, Moss DJ, Sculley TB, Misko IS.

Scand J Immunol. 1991 Apr;33(4):411-20.

PMID:
1708166
38.

Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.

Misko IS, Schmidt C, Moss DJ, Burrows SR, Sculley TB.

J Gen Virol. 1991 Feb;72 ( Pt 2):405-9.

PMID:
1704413
40.

Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.

Moss DJ, Misko IS, Sculley TB, Apolloni A, Khanna R, Burrows SR.

Springer Semin Immunopathol. 1991;13(2):147-56. Review. No abstract available.

PMID:
1724100
41.

Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cells.

Misko IS, Schmidt C, Martin N, Moss DJ, Sculley TB, Burrows S, Burman KJ.

Int J Cancer. 1990 Sep 15;46(3):399-404.

PMID:
2168343
42.

Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.

Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA.

J Infect Dis. 1990 Sep;162(3):643-8.

PMID:
2167337
43.

An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.

Burrows SR, Misko IS, Sculley TB, Schmidt C, Moss DJ.

J Virol. 1990 Aug;64(8):3974-6.

44.

Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants.

Burrows SR, Misko IS, Sculley TB, Schmidt C, Gang D, Moss DJ.

Cell Immunol. 1990 Apr 15;127(1):47-55.

PMID:
1690609
45.
46.

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).

Burrows SR, Sculley TB, Misko IS, Schmidt C, Moss DJ.

J Exp Med. 1990 Jan 1;171(1):345-9.

47.

Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.

Sculley TB, Apolloni A, Stumm R, Moss DJ, Mueller-Lantczh N, Misko IS, Cooper DA.

Virology. 1989 Aug;171(2):401-8.

PMID:
2548326
48.

Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus.

Sculley TB, Cross SM, Borrow P, Cooper DA.

J Infect Dis. 1988 Jul;158(1):186-92.

PMID:
2839581
49.

Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.

Moss DJ, Misko IS, Burrows SR, Burman K, McCarthy R, Sculley TB.

Nature. 1988 Feb 25;331(6158):719-21.

PMID:
2830541
50.

Epstein-Barr virus nuclear antigens 1 and 2 in Burkitt lymphoma cell lines containing either 'A'- or 'B'-type virus.

Sculley TB, Sculley DG, Pope JH, Bornkamm GW, Lenoir GM, Rickinson AB.

Intervirology. 1988;29(2):77-85.

PMID:
2842274

Supplemental Content

Loading ...
Support Center